Literature DB >> 1639275

Polymorphism at codon 72 of the p53 gene in human acute myelogenous leukemia.

W Zhang1, G Hu, A Deisseroth.   

Abstract

A common polymorphism at codon 72 of the p53 gene in patients with acute myelogenous leukemia (AML) was analyzed by single-strand conformation polymorphism assay and sodium dodecyl sulfate polyacrylamide-gel electrophoresis of immunoprecipitated 35S-labeled P53 protein. No association between this polymorphism and a marked predisposition to AML was found. The half-lives of these two polymorphic forms of P53 were equivalent in normal phytohemagglutinin-stimulated lymphocytes, while the P53 Pro72 isoform was found to be twice as stable as the Arg72 isoform in Daudi cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639275     DOI: 10.1016/0378-1119(92)90738-b

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  10 in total

1.  DNA sequence variants of p53: cancer and aging.

Authors:  Y Sun; C Keshava; D S Sharp; A Weston; E C McCanlies
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

2.  The p53 status in juvenile chronic arthritis and rheumatoid arthritis.

Authors:  H Taubert; B Thamm; A Meye; F Bartel; A K Rost; D Heidenreich; V John; J Brandt; M Bache; P Würl; H Schmidt; D Riemann
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 3.  Association of p53 codon 72 polymorphism with prostate cancer: an update meta-analysis.

Authors:  Yu Lu; Yanqiong Liu; Jie Zeng; Yu He; Qiliu Peng; Yan Deng; Jian Wang; Li Xie; Taijie Li; Xue Qin; Shan Li
Journal:  Tumour Biol       Date:  2014-02-01

4.  p53 codon 72 polymorphism and hematological cancer risk: an update meta-analysis.

Authors:  Yu Weng; Liqin Lu; Guorong Yuan; Jing Guo; Zhizhong Zhang; Xinyou Xie; Guangdi Chen; Jun Zhang
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

5.  Association between p53 Pro72Arg polymorphism and prostate cancer risk: a meta-analysis.

Authors:  Lifeng Zhang; Ning Shao; Qianqian Yu; Lixin Hua; Yuanyuan Mi; Ninghan Feng
Journal:  J Biomed Res       Date:  2011-01

6.  A temperature-sensitive mutant of human p53.

Authors:  W Zhang; X Y Guo; G Y Hu; W B Liu; J W Shay; A B Deisseroth
Journal:  EMBO J       Date:  1994-06-01       Impact factor: 11.598

7.  The association between TP53 Arg72pro polymorphism and non-melanoma skin cancer risk: a meta-analysis including 7,107 subjects.

Authors:  Xueling Yang; Baohong Yang; Ya Liu; Shanshan Xu; Bo Li
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

8.  Molecular and immunohistochemical analysis of P53 in phaeochromocytoma.

Authors:  P L Dahia; R C Aguiar; A M Tsanaclis; I Bendit; S P Bydlowski; N M Abelin; S P Toledo
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

9.  MDM2 gene SNP309 T/G and p53 gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European Caucasians.

Authors:  Joerg Bittenbring; Frédérique Parisot; Alain Wabo; Monika Mueller; Lynn Kerschenmeyer; Markus Kreuz; Lorenz Truemper; Olfert Landt; Alain Menzel; Michael Pfreundschuh; Klaus Roemer
Journal:  BMC Cancer       Date:  2008-04-23       Impact factor: 4.430

10.  Allelic frequency of p53 gene codon 72 polymorphism in urologic cancers.

Authors:  W J Wu; Y Kakehi; T Habuchi; H Kinoshita; O Ogawa; T Terachi; C H Huang; C P Chiang; O Yoshida
Journal:  Jpn J Cancer Res       Date:  1995-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.